Gene editing system restores dystrophin function in stem cells from patients with Duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD) is a muscle degeneration disorder caused by mutations affecting the dystrophin gene. On August 24 in the journal Stem Cell Reports, researchers show how a dual CRISPR RNA method restored dystrophin protein function in induced pluripotent stem cells derived from DMD patients.

Leave A Comment

Your email address will not be published. Required fields are marked *